Survival of gastric cancer in China from 2000 to 2022: A nationwide systematic review of hospital-based studies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Survival of gastric cancer in China from 2000 to 2022: A nationwide systematic review of hospital-based studies

Published:2022-12-17 Issue: Volume:12 Page:
ISSN:2047-2978
Container-title:Journal of Global Health
language:
Short-container-title:J Glob Health

Author:

Li Houqiang¹,Zhang Han¹,Zhang Hujia¹,Wang Youxin²,Wang Xiaobing³,Hou Haifeng⁴,

Affiliation:

1. School of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China

2. Beijing Key Laboratory of Clinical Epidemiology, School of Public Health, Capital Medical University

3. Cancer Hospital, Chinese Academy of Medical Sciences

4. School of Public Health and The Second Affiliated Hospital of Shandong First Medical University, Taian, China

Publisher

International Society of Global Health

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference37 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.;Sung;CA Cancer J Clin,2021

2. Worldwide trends in gastric cancer mortality (1980-2011), with predictions to 2015, and incidence by subtype.;Ferro;Eur J Cancer,2014

3. Global Patterns and Trends in Gastric Cancer Incidence Rates (1988-2012) and Predictions to 2030.;Lin;Gastroenterology,2021

4. Burden of Gastric Cancer.;Thrift;Clin Gastroenterol Hepatol,2020

5. Gastric cancer.;Smyth;Lancet,2020

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of Deep Learning Model and Machine Learning Detection Algorithm for Gastric Cancer Patients Undergoing Chemotherapy;Journal of Biomedical Nanotechnology;2024-09-01

2. Cellular and Molecular Mechanisms of Chemoresistance for Gastric Cancer;International Journal of General Medicine;2024-08

3. Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors for new-onset gastric cancer and gastric diseases in patients with type 2 diabetes mellitus: a population-based cohort study;Gastric Cancer;2024-06-10

4. Cost-effectiveness of tislelizumab plus chemotherapy vs chemotherapy as first-line treatment of PD-L1 positive advanced gastric or gastroesophageal junction adenocarcinoma from a Chinese perspective;Expert Review of Gastroenterology & Hepatology;2024-06-02

5. Asiaticoside promoted ferroptosis and suppressed immune escape in gastric cancer cells by downregulating the Wnt/β-catenin pathway;International Immunopharmacology;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3